IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort study
about
Stat3 is a candidate epigenetic biomarker of perinatal Bisphenol A exposure associated with murine hepatic tumors with implications for human healthIncreased B7-H4 expression during esophageal squamous cell carcinogenesis is associated with IL-6/STAT3 signaling pathway activation in miceKnockout of the Nogo-B Gene Attenuates Tumor Growth and Metastasis in Hepatocellular Carcinoma.Long noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transitionExploration and Validation of C-Reactive Protein/Albumin Ratio as a Novel Inflammation-Based Prognostic Marker in Nasopharyngeal Carcinoma.Recombinant soluble gp130 protein reduces DEN-induced primary hepatocellular carcinoma in mice.CCL20-CCR6 Cytokine Network Facilitate Treg Activity in Advanced Grades and Metastatic Variants of Hepatocellular Carcinoma.Stattic Enhances Radiosensitivity and Reduces Radio-Induced Migration and Invasion in HCC Cell Lines through an Apoptosis Pathway.Involvement of soluble B7-H3 in combination with the serum inflammatory cytokines interleukin-17, -8 and -6 in the diagnosis of hepatocellular carcinoma.Novel Indole-fused benzo-oxazepines (IFBOs) inhibit invasion of hepatocellular carcinoma by targeting IL-6 mediated JAK2/STAT3 oncogenic signals.Liver Illness and Psoriatic Patients.IL-17A promotes the invasion-metastasis cascade via the AKT pathway in hepatocellular carcinoma.IL-6 and IL-8 Serum Levels Predict Tumor Response and Overall Survival after TACE for Primary and Secondary Hepatic Malignancies
P2860
Q28834275-95EDF2F2-1423-4DA3-B64C-3F14AE66FE5AQ33598323-73EEAD07-7253-449A-AC88-D236578DDDC3Q33813952-4ED9BDA6-7CF5-448F-96A9-57AB201464AEQ36144048-C4F95D4C-45EB-48AF-A12A-C604D26295BBQ37133633-D0A64EE4-9863-4214-A984-3EEF5D55C536Q38778160-8275ECE7-F523-4AD9-B6C2-5085813B7088Q41020048-DC6064E2-EEBD-48A7-ADEB-3AD3B60BFB4DQ47096604-A88A824B-DCFA-4BD7-B2FE-F2E81F282B64Q49320250-B30C57E2-00A7-494B-B4BC-7757EB086936Q52322961-E7B69454-BD1E-499A-8F54-74B24EE50393Q54254957-4087EB32-6774-4C85-8C73-91DCA77E7859Q54940618-0589B464-85D4-461B-B176-0BA63FF04E74Q58869848-88A45A13-A2D9-40E8-AC37-8C7CAF873F3D
P2860
IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort study
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
IL-6, through p-STAT3 rather t ...... inoma patients: a cohort study
@ast
IL-6, through p-STAT3 rather t ...... inoma patients: a cohort study
@en
type
label
IL-6, through p-STAT3 rather t ...... inoma patients: a cohort study
@ast
IL-6, through p-STAT3 rather t ...... inoma patients: a cohort study
@en
prefLabel
IL-6, through p-STAT3 rather t ...... inoma patients: a cohort study
@ast
IL-6, through p-STAT3 rather t ...... inoma patients: a cohort study
@en
P2093
P2860
P1433
P1476
IL-6, through p-STAT3 rather t ...... inoma patients: a cohort study
@en
P2093
Cheng-Ju Yu
Chun-Lung Feng
Jung-Ta Kao
Shu-Mei Tsai
Yao-Li Chen
Yi-Ying Wu
P2860
P2888
P356
10.1186/S12876-015-0283-5
P577
2015-04-25T00:00:00Z
P5875
P6179
1030079774